These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 30912953)

  • 1. Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration.
    Qiu F; Meng T; Chen Q; Zhou K; Shao Y; Matlock G; Ma X; Wu W; Du Y; Wang X; Deng G; Ma JX; Xu Q
    Mol Pharm; 2019 May; 16(5):1958-1970. PubMed ID: 30912953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Effects of PPARα Agonist on Ocular Neovascularization in Models Recapitulating Neovascular Age-Related Macular Degeneration.
    Qiu F; Matlock G; Chen Q; Zhou K; Du Y; Wang X; Ma JX
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5065-5075. PubMed ID: 28980001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects of PPARα agonists on diabetic retinopathy in type 1 diabetes models.
    Chen Y; Hu Y; Lin M; Jenkins AJ; Keech AC; Mott R; Lyons TJ; Ma JX
    Diabetes; 2013 Jan; 62(1):261-72. PubMed ID: 23043158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy.
    Deng G; Moran EP; Cheng R; Matlock G; Zhou K; Moran D; Chen D; Yu Q; Ma JX
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5030-5042. PubMed ID: 28979999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(lactic-co-glycolic acid) nanoparticle-mediated interleukin-12 delivery for the treatment of diabetic retinopathy.
    Zeng L; Ma W; Shi L; Chen X; Wu R; Zhang Y; Chen H; Chen H
    Int J Nanomedicine; 2019; 14():6357-6369. PubMed ID: 31496691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory and antiangiogenic effects of nanoparticle-mediated delivery of a natural angiogenic inhibitor.
    Jin J; Zhou KK; Park K; Hu Y; Xu X; Zheng Z; Tyagi P; Kompella UB; Ma JX
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6230-7. PubMed ID: 21357401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
    Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle-mediated expression of an angiogenic inhibitor ameliorates ischemia-induced retinal neovascularization and diabetes-induced retinal vascular leakage.
    Park K; Chen Y; Hu Y; Mayo AS; Kompella UB; Longeras R; Ma JX
    Diabetes; 2009 Aug; 58(8):1902-13. PubMed ID: 19491211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Effects of Fenofibrate Nano-Emulsion Eye Drops on Retinal Vascular Leakage and Neovascularization.
    Huang L; Liang W; Zhou K; Wassel RA; Ridge ZD; Ma JX; Wang B
    Biology (Basel); 2021 Dec; 10(12):. PubMed ID: 34943243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation.
    Liu Q; Zhang F; Zhang X; Cheng R; Ma JX; Yi J; Li J
    Mol Cell Biochem; 2018 Aug; 445(1-2):105-115. PubMed ID: 29264825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphomannopentaose sulfate (PI-88) inhibits retinal leukostasis in diabetic rat.
    Ma P; Luo Y; Zhu X; Ma H; Hu J; Tang S
    Biochem Biophys Res Commun; 2009 Mar; 380(2):402-6. PubMed ID: 19250642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina.
    Masuzawa K; Goto K; Jesmin S; Maeda S; Miyauchi T; Kaji Y; Oshika T; Hori S
    Curr Eye Res; 2006 Jan; 31(1):79-89. PubMed ID: 16421022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of elema-1,3,7(11),8-tetraen-8,12-lactam from Curcuma wenyujin on diabetic retinopathy via anti-inflammatory and anti-angiogenic pathways.
    Cai Y; Tu H; Wu C; Liu T; Chen S; Shen L; Xiao Q; Zhao S; Xu S; Lin W; Yan P; Dong J
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116843. PubMed ID: 37414197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor α protects capillary pericytes in the retina.
    Ding L; Cheng R; Hu Y; Takahashi Y; Jenkins AJ; Keech AC; Humphries KM; Gu X; Elliott MH; Xia X; Ma JX
    Am J Pathol; 2014 Oct; 184(10):2709-20. PubMed ID: 25108226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JP1, a polypeptide specifically targeting integrin αVβ3, ameliorates choroidal neovascularization and diabetic retinopathy in mice.
    Xie Z; Wu XJ; Cheng RW; Cui JH; Yuan ST; Zhou JW; Liu QH
    Acta Pharmacol Sin; 2023 Apr; 44(4):897-912. PubMed ID: 36280689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression, distribution and function of kinin B
    Hachana S; Bhat M; Sénécal J; Huppé-Gourgues F; Couture R; Vaucher E
    Br J Pharmacol; 2018 Mar; 175(6):968-983. PubMed ID: 29285756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potent small molecule integrin antagonist THR-687 is a promising next-generation therapy for retinal vascular disorders.
    Hu TT; Vanhove M; Porcu M; Van Hove I; Van Bergen T; Jonckx B; Barbeaux P; Vermassen E; Feyen JHM
    Exp Eye Res; 2019 Mar; 180():43-52. PubMed ID: 30472075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischaemia-induced retinal neovascularisation and diabetic retinopathy in mice with conditional knockout of hypoxia-inducible factor-1 in retinal Müller cells.
    Lin M; Chen Y; Jin J; Hu Y; Zhou KK; Zhu M; Le YZ; Ge J; Johnson RS; Ma JX
    Diabetologia; 2011 Jun; 54(6):1554-66. PubMed ID: 21360191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anisotropic poly(lactic-co-glycolic acid) microparticles enable sustained release of a peptide for long-term inhibition of ocular neovascularization.
    Kim J; Lima E Silva R; Shmueli RB; Mirando AC; Tzeng SY; Pandey NB; Ben-Akiva E; Popel AS; Campochiaro PA; Green JJ
    Acta Biomater; 2019 Oct; 97():451-460. PubMed ID: 31374338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina.
    Masuzawa K; Jesmin S; Maeda S; Zaedi S; Shimojo N; Miyauchi T; Goto K
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1090-4. PubMed ID: 16741055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.